Cohance Lifesciences Limited
COHANCE
Clasificación en acciones
#6305
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Precio por acción
$5.14
Capitalización bursátil
$1.97B
Cambio (1 día)
1.85%
Cambio (1 año)
-56.59%
País
IN
Comercio Cohance Lifesciences Limited (COHANCE)
Categoría
Healthcare
Ratio P/B de Cohance Lifesciences Limited (COHANCE)
Ratio P/B al October 2026 TTM: 22.54
Según los informes financieros más recientes y el precio de las acciones de Cohance Lifesciences Limited, el ratio P/B actual (TTM) es 22.54. Al final de 2024, el ratio P/B era 8.31.
Historial del ratio P/B de Cohance Lifesciences Limited desde 2019 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 22.54 | 41.50% |
| 2025 | 15.93 | 91.72% |
| 2024 | 8.31 | 19.91% |
| 2023 | 6.93 | -32.77% |
| 2022 | 10.31 | -3.75% |
| 2021 | 10.71 | 253.56% |
| 2020 | 3.03 | -58.32% |
| 2019 | 7.27 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | -77.64% |
IN
|
